Canopy Cancer Collective Registry for GI Cancers
This is an observational study, called a registry, that collects information about people with gastrointestinal (GI) cancers, including pancreatic and colorectal cancer. The study aims to gather comprehensive data on your past medical history and future health experiences. This information will help researchers better understand these cancers, find ways to improve patient care, and identify best practices. The goal is to enroll 100,000 participants. You may be able to join if you are 18 or older and have a confirmed GI cancer diagnosis. This registry does not involve any specific treatments or interventions.
- Study design
- This is an observational registry study, not a treatment trial. It aims to collect data from 100,000 participants.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for up to 120 months (10 years) to measure the number of people enrolled in the registry.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
The Canopy Cancer Collective Clinical Registry Protocol
At a glance
Conditions
Where it's being run
10 sites across 7 statesStudy leadership
- Michael Pishvaian, MD, PhD · STUDY_CHAIR · Johns Hopkins University
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Number of participants enrolled in registryUp to 120 months
Count of participants enrolled in the Canopy Cancer Collective GI cancer registry (prospective + retrospective).